Key facts
- This page summarizes Nir Sassi's Form 4 filing for Indaptus Therapeutics, Inc. (INDP).
- 1 reported transaction and 0 derivative rows are listed below.
- Filing timestamp: 29 Dec 2025, 16:01.
Nir Sassi - 22 Dec 2025 Form 4 Insider Report for Indaptus Therapeutics, Inc. (INDP)
- Issuer symbol
- INDP
- Report date
- 22 Dec 2025
- Net transaction value
- +$54,319
- Form type
- 4
- Accepted by SEC
- 29 Dec 2025, 16:01:23 UTC
- Previous filing
- 11 Apr 2025
- SEC filing
- View on sec.gov
- Reporting owner signature
- /s/ Nir Sassi
SEC evidence
4 facts
Reporting owner
1 fact
Key filing fact
Nir Sassi filed Form 4 for Indaptus Therapeutics, Inc. (INDP) on 29 Dec 2025.
Change
- Previous filing in this sequence was filed on 11 Apr 2025.
- Current net transaction value: +$54,319.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
See Original Filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001760673
Primary reporting owner
Sassi Nir
- Relationship
- Chief Financial Officer
- Address
- C/O INDAPTUS THERAPEUTICS, INC, 3 COLUMBUS CIRCLE, 15TH FLOOR, NEW YORK
- Signature
- /s/ Nir Sassi
- Signature date
- 29 Dec 2025
Reported transactions
INDP
transaction
Common Stock
Award
- Transaction value
- $54,319
- Shares
- +26,758
- Change %
- Price
- $2.03
- Shares after
- 26,758
- Date
- 22 Dec 2025
- Ownership
- Direct
- Footnotes
- F1
* indicates a reported price that failed the local validity check.
Explanation of Responses:
| Id | Content |
|---|---|
| F1 | The Reporting Person acquired 26,758 shares of common stock pursuant to an amendment to his employment agreement, in connection with the signing of a securities purchase agreement, dated December 22, 2025. |